{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T01:54:58Z","timestamp":1794275698307,"version":"4.9.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T00:00:00Z","timestamp":1662508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T00:00:00Z","timestamp":1662508800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32222084, 32002331 and 32172907"],"award-info":[{"award-number":["32222084, 32002331 and 32172907"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The prevalence of multidrug-resistant (MDR) pathogens raises public fears of untreatable infections and represents a huge health risk. There is an urgent need to exploit novel antimicrobial agents. Due to the unique mechanisms, antimicrobial peptides (AMPs) with a low probability to achieve resistance are regarded as potential antibiotic alternatives to address this issue. Herein, we develop a panel of synthetic peptide compounds with novel structures based on the database filters technology (DFT), and the lead peptide LI14 shows potent antibacterial activity against all tested drug-resistant bacteria. LI14 exhibits rapid bactericidal activity and excellent anti-biofilm and -persisters activity, simultaneously showing a low propensity to induce resistance. Moreover, LI14 shows tolerance against pH, temperatures, and pepsin treatment, and no detectable toxicity both in vitro and in vivo. Mechanistic studies revealed that LI14 induces membrane damage by targeting bacterial-specific membrane components and dissipates the proton motive force (PMF), thereby resulting in metabolic perturbations and the accumulation of toxic metabolic products. Furthermore, LI14 sensitizes clinically relevant antibiotics against MDR bacteria. In animal models of infection, LI14 or combined with antibiotics are effective against drug-resistant pathogens. These findings suggest that LI14 is a promising antibiotic candidate to tackle MDR bacterial infections.<\/jats:p>","DOI":"10.1038\/s42003-022-03899-4","type":"journal-article","created":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T14:09:08Z","timestamp":1662559748000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":118,"title":["The antimicrobial peptide LI14 combats multidrug-resistant bacterial infections"],"prefix":"10.1038","volume":"5","author":[{"given":"Jingru","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dejuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6486-9600","authenticated-orcid":false,"given":"Zhiqiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9622-6471","authenticated-orcid":false,"given":"Yuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,7]]},"reference":[{"key":"3899_CR1","unstructured":"O\u2019neill, J. Tackling Drug-resistant Infections Globally: Final Report And Recommendations (Review on Antimicrobial Resistance, 2016)."},{"key":"3899_CR2","doi-asserted-by":"publisher","first-page":"1901872","DOI":"10.1002\/advs.201901872","volume":"7","author":"Y-X Ma","year":"2020","unstructured":"Ma, Y.-X. et al. Considerations and caveats in combating ESKAPE pathogens against nosocomial infections. Adv. Sci. 7, 1901872 (2020).","journal-title":"Adv. Sci."},{"key":"3899_CR3","doi-asserted-by":"crossref","unstructured":"De Oliveira, D. M. P. et al. Antimicrobial resistance in ESKAPE pathogens. Clin. Microbiol. Rev. 33, e00181-19 (2020).","DOI":"10.1128\/CMR.00181-19"},{"key":"3899_CR4","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/S1473-3099(11)70059-7","volume":"11","author":"TR Walsh","year":"2011","unstructured":"Walsh, T. R., Weeks, J., Livermore, D. M. & Toleman, M. A. Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study. Lancet Infect. Dis. 11, 355\u2013362 (2011).","journal-title":"Lancet Infect. Dis."},{"key":"3899_CR5","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S1473-3099(15)00424-7","volume":"16","author":"Y-Y Liu","year":"2016","unstructured":"Liu, Y.-Y. et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect. Dis. 16, 161\u2013168 (2016).","journal-title":"Lancet Infect. Dis."},{"key":"3899_CR6","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1038\/s41564-019-0496-4","volume":"4","author":"J Sun","year":"2019","unstructured":"Sun, J. et al. Plasmid-encoded tet(X) genes that confer high-level tigecycline resistance in Escherichia coli. Nat. Microbiol. 4, 1457\u20131464 (2019).","journal-title":"Nat. Microbiol."},{"key":"3899_CR7","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1038\/s41564-019-0445-2","volume":"4","author":"T He","year":"2019","unstructured":"He, T. et al. Emergence of plasmid-mediated high-level tigecycline resistance genes in animals and humans. Nat. Microbiol. 4, 1450\u20131456 (2019).","journal-title":"Nat. Microbiol."},{"key":"3899_CR8","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1128\/CMR.15.2.167-193.2002","volume":"15","author":"RM Donlan","year":"2002","unstructured":"Donlan, R. M. & Costerton, J. W. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin. Microbiol. Rev. 15, 167\u2013193 (2002).","journal-title":"Clin. Microbiol. Rev."},{"key":"3899_CR9","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/nrmicro.2017.99","volume":"15","author":"H Koo","year":"2017","unstructured":"Koo, H., Allan, R. N., Howlin, R. P., Stoodley, P. & Hall-Stoodley, L. Targeting microbial biofilms: current and prospective therapeutic strategies. Nat. Rev. Microbiol. 15, 740\u2013755 (2017).","journal-title":"Nat. Rev. Microbiol."},{"key":"3899_CR10","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.cmet.2019.06.009","volume":"30","author":"JM Stokes","year":"2019","unstructured":"Stokes, J. M., Lopatkin, A. J., Lobritz, M. A. & Collins, J. J. Bacterial metabolism and antibiotic efficacy. Cell Metab. 30, 251\u2013259 (2019).","journal-title":"Cell Metab."},{"key":"3899_CR11","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1146\/annurev-micro-020518-115650","volume":"73","author":"B Gollan","year":"2019","unstructured":"Gollan, B., Grabe, G., Michaux, C. & Helaine, S. Bacterial persisters and infection: past, present, and progressing. Annu. Rev. Microbiol. 73, 359\u2013385 (2019).","journal-title":"Annu. Rev. Microbiol."},{"key":"3899_CR12","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nrmicro.2017.42","volume":"15","author":"RA Fisher","year":"2017","unstructured":"Fisher, R. A., Gollan, B. & Helaine, S. Persistent bacterial infections and persister cells. Nat. Rev. Microbiol. 15, 453\u2013464 (2017).","journal-title":"Nat. Rev. Microbiol."},{"key":"3899_CR13","doi-asserted-by":"publisher","first-page":"eaau5480","DOI":"10.1126\/science.aau5480","volume":"368","author":"BP Lazzaro","year":"2020","unstructured":"Lazzaro, B. P., Zasloff, M. & Rolff, J. Antimicrobial peptides: application informed by evolution. Science 368, eaau5480 (2020).","journal-title":"Science"},{"key":"3899_CR14","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/s41573-019-0058-8","volume":"19","author":"N Mookherjee","year":"2020","unstructured":"Mookherjee, N., Anderson, M. A., Haagsman, H. P. & Davidson, D. J. Antimicrobial host defence peptides: functions and clinical potential. Nat. Rev. Drug Discov. 19, 311\u2013332 (2020).","journal-title":"Nat. Rev. Drug Discov."},{"key":"3899_CR15","doi-asserted-by":"publisher","first-page":"e216","DOI":"10.1016\/S1473-3099(20)30327-3","volume":"20","author":"M Magana","year":"2020","unstructured":"Magana, M. et al. The value of antimicrobial peptides in the age of resistance. Lancet Infect. Dis. 20, e216\u2013e230 (2020).","journal-title":"Lancet Infect. Dis."},{"key":"3899_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12364-6","volume":"10","author":"R Spohn","year":"2019","unstructured":"Spohn, R. et al. Integrated evolutionary analysis reveals antimicrobial peptides with limited resistance. Nat. Commun. 10, 4538 (2019).","journal-title":"Nat. Commun."},{"key":"3899_CR17","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1080\/07388551.2020.1796576","volume":"40","author":"M Mahlapuu","year":"2020","unstructured":"Mahlapuu, M., Bj\u00f6rn, C. & Ekblom, J. Antimicrobial peptides as therapeutic agents: opportunities and challenges. Crit. Rev. Biotechnol. 40, 978\u2013992 (2020).","journal-title":"Crit. Rev. Biotechnol."},{"key":"3899_CR18","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1002\/med.21542","volume":"39","author":"J Wang","year":"2019","unstructured":"Wang, J. et al. Antimicrobial peptides: Promising alternatives in the post feeding antibiotic era. Med. Res. Rev. 39, 831\u2013859 (2019).","journal-title":"Med. Res. Rev."},{"key":"3899_CR19","doi-asserted-by":"publisher","first-page":"105276","DOI":"10.1016\/j.phrs.2020.105276","volume":"163","author":"Y Liu","year":"2021","unstructured":"Liu, Y. et al. The revitalization of antimicrobial peptides in the resistance era. Pharmacol. Res. 163, 105276 (2021).","journal-title":"Pharmacol. Res."},{"key":"3899_CR20","doi-asserted-by":"publisher","first-page":"101229","DOI":"10.1016\/j.nantod.2021.101229","volume":"39","author":"P Tan","year":"2021","unstructured":"Tan, P., Fu, H. & Ma, X. Design, optimization, and nanotechnology of antimicrobial peptides: From exploration to applications. Nano Today 39, 101229 (2021).","journal-title":"Nano Today"},{"key":"3899_CR21","doi-asserted-by":"publisher","first-page":"eaan4044","DOI":"10.1126\/scitranslmed.aan4044","volume":"10","author":"AB De","year":"2018","unstructured":"De, A. B. et al. The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms. Sci. Transl. Med. 10, eaan4044 (2018).","journal-title":"Sci. Transl. Med."},{"key":"3899_CR22","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.7150\/thno.39157","volume":"10","author":"L Ma","year":"2020","unstructured":"Ma, L. et al. Potent antibacterial activity of MSI-1 derived from the magainin 2 peptide against drug-resistant bacteria. Theranostics 10, 1373\u20131390 (2020).","journal-title":"Theranostics"},{"key":"3899_CR23","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1128\/AAC.01448-09","volume":"54","author":"G Wang","year":"2010","unstructured":"Wang, G., Watson, K. M., Peterkofsky, A. & Buckheit, R. W. Jr. Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database. Antimicrob. Agents Chemother. 54, 1343\u20131346 (2010).","journal-title":"Antimicrob. Agents Chemother."},{"key":"3899_CR24","doi-asserted-by":"publisher","first-page":"D1087","DOI":"10.1093\/nar\/gkv1278","volume":"44","author":"G Wang","year":"2016","unstructured":"Wang, G., Li, X. & Wang, Z. APD3: the antimicrobial peptide database as a tool for research and education. Nucleic Acids Res. 44, D1087\u20131093 (2016).","journal-title":"Nucleic Acids Res."},{"key":"3899_CR25","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1021\/acs.jmedchem.6b01457","volume":"60","author":"X Dou","year":"2017","unstructured":"Dou, X., Zhu, X., Wang, J., Dong, N. & Shan, A. Novel design of heptad amphiphiles to enhance cell selectivity, salt resistance, antibiofilm properties and their membrane-disruptive mechanism. J. Med. Chem. 60, 2257\u20132270 (2017).","journal-title":"J. Med. Chem."},{"key":"3899_CR26","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.cell.2020.01.021","volume":"180","author":"JM Stokes","year":"2020","unstructured":"Stokes, J. M. et al. A deep learning approach to antibiotic discovery. Cell 180, 688\u2013702 e613 (2020).","journal-title":"Cell"},{"key":"3899_CR27","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/s41579-019-0196-3","volume":"17","author":"NQ Balaban","year":"2019","unstructured":"Balaban, N. Q. et al. Definitions and guidelines for research on antibiotic persistence. Nat. Rev. Microbiol. 17, 441\u2013448 (2019).","journal-title":"Nat. Rev. Microbiol."},{"key":"3899_CR28","doi-asserted-by":"crossref","unstructured":"de Breij, A. et al. The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms. Sci. Transl. Med. 10, eaan4044 (2018).","DOI":"10.1126\/scitranslmed.aan4044"},{"key":"3899_CR29","doi-asserted-by":"publisher","first-page":"438","DOI":"10.3390\/pharmaceutics13040438","volume":"13","author":"J Shi","year":"2021","unstructured":"Shi, J. et al. Amphipathic peptide antibiotics with potent activity against multidrug-resistant pathogens. Pharmaceutics 13, 438 (2021).","journal-title":"Pharmaceutics"},{"key":"3899_CR30","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1038\/s41564-020-0723-z","volume":"5","author":"M Song","year":"2020","unstructured":"Song, M. et al. A broad-spectrum antibiotic adjuvant reverses multidrug-resistant Gram-negative pathogens. Nat. Microbiol. 5, 1040\u20131050 (2020).","journal-title":"Nat. Microbiol."},{"key":"3899_CR31","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1038\/nbt1267","volume":"24","author":"RE Hancock","year":"2006","unstructured":"Hancock, R. E. & Sahl, H. G. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat. Biotechnol. 24, 1551\u20131557 (2006).","journal-title":"Nat. Biotechnol."},{"key":"3899_CR32","doi-asserted-by":"publisher","first-page":"e2100749","DOI":"10.1002\/advs.202100749","volume":"8","author":"M Song","year":"2021","unstructured":"Song, M. et al. Plant natural flavonoids against multidrug resistant pathogens. Adv. Sci. 8, e2100749 (2021).","journal-title":"Adv. Sci."},{"key":"3899_CR33","doi-asserted-by":"publisher","first-page":"13588","DOI":"10.1073\/pnas.1609893113","volume":"113","author":"EY Lee","year":"2016","unstructured":"Lee, E. Y., Fulan, B. M., Wong, G. C. & Ferguson, A. L. Mapping membrane activity in undiscovered peptide sequence space using machine learning. Proc. Natl Acad. Sci. USA 113, 13588\u201313593 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"3899_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22485-6","volume":"12","author":"F Wong","year":"2021","unstructured":"Wong, F. et al. Cytoplasmic condensation induced by membrane damage is associated with antibiotic lethality. Nat. Commun. 12, 2321 (2021).","journal-title":"Nat. Commun."},{"key":"3899_CR35","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1016\/j.cell.2020.05.005","volume":"181","author":"JK Martin 2nd","year":"2020","unstructured":"Martin, J. K. 2nd et al. A dual-mechanism antibiotic kills gram-negative bacteria and avoids drug resistance. Cell 181, 1518\u20131532 e1514 (2020).","journal-title":"Cell"},{"key":"3899_CR36","doi-asserted-by":"publisher","first-page":"e1006876","DOI":"10.1371\/journal.ppat.1006876","volume":"14","author":"D Saeloh","year":"2018","unstructured":"Saeloh, D. et al. The novel antibiotic rhodomyrtone traps membrane proteins in vesicles with increased fluidity. PLoS Pathog. 14, e1006876 (2018).","journal-title":"PLoS Pathog."},{"key":"3899_CR37","doi-asserted-by":"publisher","first-page":"16529","DOI":"10.1073\/pnas.1904700116","volume":"116","author":"W Kim","year":"2019","unstructured":"Kim, W. et al. A selective membrane-targeting repurposed antibiotic with activity against persistent methicillin-resistant Staphylococcus aureus. Proc. Natl Acad. Sci. USA 116, 16529\u201316534 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"3899_CR38","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1016\/j.chembiol.2013.07.006","volume":"20","author":"MA Farha","year":"2013","unstructured":"Farha, M. A., Verschoor, C. P., Bowdish, D. & Brown, E. D. Collapsing the proton motive force to identify synergistic combinations against Staphylococcus aureus. Chem. Biol. 20, 1168\u20131178 (2013).","journal-title":"Chem. Biol."},{"key":"3899_CR39","doi-asserted-by":"publisher","first-page":"e67718","DOI":"10.1371\/journal.pone.0067718","volume":"8","author":"R Kurre","year":"2013","unstructured":"Kurre, R., Kouzel, N., Ramakrishnan, K., Oldewurtel, E. R. & Maier, B. Speed switching of gonococcal surface motility correlates with proton motive force. PLoS ONE 8, e67718 (2013).","journal-title":"PLoS ONE"},{"key":"3899_CR40","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1038\/s42003-021-02854-z","volume":"4","author":"Y Liu","year":"2021","unstructured":"Liu, Y. et al. Reversion of antibiotic resistance in multidrug-resistant pathogens using non-antibiotic pharmaceutical benzydamine. Commun. Biol. 4, 1328 (2021).","journal-title":"Commun. Biol."},{"key":"3899_CR41","doi-asserted-by":"publisher","first-page":"8173","DOI":"10.1073\/pnas.1509743112","volume":"112","author":"MA Lobritz","year":"2015","unstructured":"Lobritz, M. A. et al. Antibiotic efficacy is linked to bacterial cellular respiration. Proc. Natl Acad. Sci. USA 112, 8173 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"3899_CR42","doi-asserted-by":"publisher","first-page":"10697","DOI":"10.7150\/thno.45951","volume":"10","author":"Y Liu","year":"2020","unstructured":"Liu, Y. et al. Melatonin overcomes MCR-mediated colistin resistance in Gram-negative pathogens. Theranostics 10, 10697\u201310711 (2020).","journal-title":"Theranostics"},{"key":"3899_CR43","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1038\/s41564-021-00912-0","volume":"6","author":"Y Liu","year":"2021","unstructured":"Liu, Y. et al. Gut microbiome alterations in high-fat-diet-fed mice are associated with antibiotic tolerance. Nat. Microbiol. 6, 874\u2013884 (2021).","journal-title":"Nat. Microbiol."},{"key":"3899_CR44","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1042\/BJ20130282","volume":"454","author":"M Halasi","year":"2013","unstructured":"Halasi, M. et al. ROS inhibitor N-acetyl-L-cysteine antagonizes the activity of proteasome inhibitors. Biochem. J. 454, 201\u2013208 (2013).","journal-title":"Biochem. J."},{"key":"3899_CR45","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1080\/1040841X.2019.1599813","volume":"45","author":"Y Liu","year":"2019","unstructured":"Liu, Y., Li, R., Xiao, X. & Wang, Z. Antibiotic adjuvants: an alternative approach to overcome multi-drug resistant Gram-negative bacteria. Crit. Rev. Microbiol. 45, 301\u2013314 (2019).","journal-title":"Crit. Rev. Microbiol."},{"key":"3899_CR46","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41586-018-0278-9","volume":"559","author":"AR Brochado","year":"2018","unstructured":"Brochado, A. R. et al. Species-specific activity of antibacterial drug combinations. Nature 559, 259\u2013263 (2018).","journal-title":"Nature"},{"key":"3899_CR47","doi-asserted-by":"publisher","first-page":"4910","DOI":"10.7150\/thno.56205","volume":"11","author":"Y Liu","year":"2021","unstructured":"Liu, Y. et al. Drug repurposing for next-generation combination therapies against multidrug-resistant bacteria. Theranostics 11, 4910\u20134928 (2021).","journal-title":"Theranostics"},{"key":"3899_CR48","doi-asserted-by":"publisher","first-page":"1902227","DOI":"10.1002\/advs.201902227","volume":"7","author":"Y Liu","year":"2020","unstructured":"Liu, Y. et al. Metformin restores tetracyclines susceptibility against multidrug resistant bacteria. Adv. Sci. 7, 1902227 (2020).","journal-title":"Adv. Sci."},{"key":"3899_CR49","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/nrd3591","volume":"11","author":"CD Fjell","year":"2012","unstructured":"Fjell, C. D., Hiss, J. A., Hancock, R. E. & Schneider, G. Designing antimicrobial peptides: form follows function. Nat. Rev. Drug Discov. 11, 37\u201351 (2012).","journal-title":"Nat. Rev. Drug Discov."},{"key":"3899_CR50","doi-asserted-by":"publisher","first-page":"22113","DOI":"10.1021\/acsami.9b04654","volume":"11","author":"Z Lai","year":"2019","unstructured":"Lai, Z. et al. Highly stabilized alpha-helical coiled coils kill gram-negative bacteria by multicomplementary mechanisms under acidic condition. ACS Appl. Mater. Interfaces 11, 22113\u201322128 (2019).","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"3899_CR51","doi-asserted-by":"publisher","first-page":"4586","DOI":"10.1021\/acs.jmedchem.9b00149","volume":"62","author":"Z Yang","year":"2019","unstructured":"Yang, Z. et al. Rational design of short peptide variants by using Kunitzin-RE, an amphibian-derived bioactivity peptide, for acquired potent broad-spectrum antimicrobial and improved therapeutic potential of commensalism coinfection of pathogens. J. Med. Chem. 62, 4586\u20134605 (2019).","journal-title":"J. Med. Chem."},{"key":"3899_CR52","doi-asserted-by":"publisher","first-page":"9421","DOI":"10.1021\/acs.jmedchem.0c00583","volume":"63","author":"Y Zhu","year":"2020","unstructured":"Zhu, Y. et al. Rational avoidance of protease cleavage sites and symmetrical end-tagging significantly enhances the stability and therapeutic potential of antimicrobial peptides. J. Med. Chem. 63, 9421\u20139435 (2020).","journal-title":"J. Med. Chem."},{"key":"3899_CR53","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.chom.2019.06.002","volume":"26","author":"J Yan","year":"2019","unstructured":"Yan, J. & Bassler, B. L. Surviving as a community: antibiotic tolerance and persistence in bacterial biofilms. Cell Host Microbe 26, 15\u201321 (2019).","journal-title":"Cell Host Microbe"},{"key":"3899_CR54","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.drup.2018.03.002","volume":"38","author":"V Defraine","year":"2018","unstructured":"Defraine, V., Fauvart, M. & Michiels, J. Fighting bacterial persistence: current and emerging anti-persister strategies and therapeutics. Drug Resist. Updat. 38, 12\u201326 (2018).","journal-title":"Drug Resist. Updat."},{"key":"3899_CR55","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/nature12790","volume":"503","author":"BP Conlon","year":"2013","unstructured":"Conlon, B. P. et al. Activated ClpP kills persisters and eradicates a chronic biofilm infection. Nature 503, 365\u2013370 (2013).","journal-title":"Nature"},{"key":"3899_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06488-4","volume":"9","author":"C Dias","year":"2018","unstructured":"Dias, C. et al. Sugar-based bactericides targeting phosphatidylethanolamine-enriched membranes. Nat. Commun. 9, 4857 (2018).","journal-title":"Nat. Commun."},{"key":"3899_CR57","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.cell.2020.02.056","volume":"181","author":"K Lewis","year":"2020","unstructured":"Lewis, K. The science of antibiotic discovery. Cell 181, 29\u201345 (2020).","journal-title":"Cell"},{"key":"3899_CR58","doi-asserted-by":"publisher","first-page":"13517","DOI":"10.1073\/pnas.1821410116","volume":"116","author":"B Mishra","year":"2019","unstructured":"Mishra, B., Lakshmaiah Narayana, J., Lushnikova, T., Wang, X. & Wang, G. Low cationicity is important for systemic in vivo efficacy of database-derived peptides against drug-resistant Gram-positive pathogens. Proc. Natl Acad. Sci. USA 116, 13517\u201313522 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"3899_CR59","doi-asserted-by":"publisher","first-page":"3409","DOI":"10.1093\/jac\/dkz230","volume":"74","author":"Y Liu","year":"2019","unstructured":"Liu, Y., Li, R., Xiao, X. & Wang, Z. Bacterial metabolism-inspired molecules to modulate antibiotic efficacy. J. Antimicrob. Chemother. 74, 3409\u20133417 (2019).","journal-title":"J. Antimicrob. Chemother."},{"key":"3899_CR60","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1016\/j.cell.2019.04.016","volume":"177","author":"JH Yang","year":"2019","unstructured":"Yang, J. H. et al. A white-box machine learning approach for revealing antibiotic mechanisms of action. Cell 177, 1649\u20131661.e1649 (2019).","journal-title":"Cell"},{"key":"3899_CR61","doi-asserted-by":"publisher","first-page":"26516","DOI":"10.1073\/pnas.1909585117","volume":"116","author":"J Mwangi","year":"2019","unstructured":"Mwangi, J. et al. The antimicrobial peptide ZY4 combats multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii infection. Proc. Natl Acad. Sci. USA 116, 26516\u201326522 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"3899_CR62","doi-asserted-by":"publisher","first-page":"26936","DOI":"10.1073\/pnas.2012379117","volume":"117","author":"ON Silva","year":"2020","unstructured":"Silva, O. N. et al. Repurposing a peptide toxin from wasp venom into antiinfectives with dual antimicrobial and immunomodulatory properties. Proc. Natl Acad. Sci. USA 117, 26936\u201326945 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"3899_CR63","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/nature14098","volume":"517","author":"LL Ling","year":"2015","unstructured":"Ling, L. L. et al. A new antibiotic kills pathogens without detectable resistance. Nature 517, 455\u2013459 (2015).","journal-title":"Nature"},{"key":"3899_CR64","doi-asserted-by":"publisher","first-page":"19446","DOI":"10.1073\/pnas.2005540117","volume":"117","author":"J Lakshmaiah Narayana","year":"2020","unstructured":"Lakshmaiah Narayana, J. et al. Two distinct amphipathic peptide antibiotics with systemic efficacy. Proc. Natl Acad. Sci. USA 117, 19446\u201319454 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"3899_CR65","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.3390\/microorganisms8091398","volume":"8","author":"Y Liu","year":"2020","unstructured":"Liu, Y. et al. Potent broad-spectrum antibacterial activity of amphiphilic peptides against multidrug-resistant bacteria. Microorganisms 8, 1398 (2020).","journal-title":"Microorganisms"},{"key":"3899_CR66","doi-asserted-by":"publisher","first-page":"105978","DOI":"10.1016\/j.phrs.2021.105978","volume":"175","author":"Y Jia","year":"2022","unstructured":"Jia, Y. et al. Melatonin prevents conjugative transfer of plasmid-mediated antibiotic resistance genes by disrupting proton motive force. Pharmacol. Res. 175, 105978 (2022).","journal-title":"Pharmacol. Res."},{"key":"3899_CR67","doi-asserted-by":"publisher","first-page":"e01313","DOI":"10.1128\/AAC.01313-19","volume":"63","author":"CW Hall","year":"2019","unstructured":"Hall, C. W., Farkas, E., Zhang, L. & Mah, T.-F. Potentiation of aminoglycoside lethality by C4-dicarboxylates requires RpoN in antibiotic-tolerant Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 63, e01313\u201301319 (2019).","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-022-03899-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-022-03899-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-022-03899-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T15:07:45Z","timestamp":1662563265000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-022-03899-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,7]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["3899"],"URL":"https:\/\/doi.org\/10.1038\/s42003-022-03899-4","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,7]]},"assertion":[{"value":"16 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"926"}}